Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (Nature Immunology, (2019), 20, 8, (992-1003), 10.1038/s41590-019-0423-0)

Jochem H. Bernink, Yoichiro Ohne, Marcel B. M. Teunissen, Jingya Wang, Jincheng Wu, Lisette Krabbendam, Christine Guntermann, Richard Volckmann, Jan Koster, Sophie van Tol, Ivan Ramirez, Yashaswi Shrestha, Menno A. de Rie, Hergen Spits, Xavier Romero Ros, Alison A. Humbles

Research output: Contribution to journalComment/Letter to the editorAcademic

1 Citation (Scopus)


In the version of this article initially published, the cell conversion was stated incorrectly (‘ILC2s to ILC1-like cells’) in the first sentence of the second paragraph in the second Results subsection; the correct description is ‘ILC1s to ILC2-like cells’. Also, the far left plot in Fig. 1d was missing the vertical axis label; this should be ‘IL-13−APC’. Finally, in the legend to Fig. 3a,b, the human ILCs were identified incorrectly (CD45+CD56‒CD127‒); the correct phenotype is CD45+CD56‒CD127+. The errors have been corrected in the HTML and PDF versions of the article.
Original languageEnglish
Pages (from-to)101
Number of pages1
JournalNature immunology
Issue number1
Publication statusPublished - 1 Jan 2020

Cite this